Actualités

Identification of a whole new type of mutation in immune deficiencie

30/01/2023

Accelerating gene therapy: assessment and prospects at the end of the DIM Gene Therapy program

24/01/2023

Covid-19: inborn errors responsible for multisystemic inflammatory syndrome in children

18/01/2023

A new tool to correct a mutation in beta-thalassemia

03/01/2023

A look at the latest advances in gene therapy

19/12/2022

A look back at the Dravet Syndrome Alliance Days

12/12/2022

A new gene therapy strategy for sickle cell disease and beta thalassemia

22/11/2022

"The systematic screening of sickle cell disease extended to the entire French population is a real victory".

18/11/2022

A key mechanism of inflammation in sickle cell disease identified for the first time

28/10/2022

Institut Imagine, Hôpital Necker-Enfants malades AP-HP and HELEBOR collaborate in a clinical and fundamental research partnership on children's pain

18/10/2022

Genetics and immunology of rare infections, a powerful tool for understanding common infections

18/08/2022

Les causes génétiques des infections graves à staphylocoques

01/08/2022

Scientists discover novel mutation associated with alternating hemiplegia of childhood

12/07/2022

Institut Imagine (Paris) will coordinate a Horizon Europe-granted project on genome editing approaches to treat sickle cell disease

28/06/2022

Covid-19: An immunological deficit explains nearly a quarter of the very rare severe forms observed in vaccinated patients

16/06/2022